Global Stem Cell Therapy for Multiple Sclerosis Market Research Report 2022

Market Analysis and Insights: Global Stem Cell Therapy for Multiple Sclerosis Market

Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision, and tingling.

The global Stem Cell Therapy for Multiple Sclerosis market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

The introduction of mesenchymal stem cells therapy is one of the most promising investigational approach to treat multiple sclerosis, the global multiple sclerosis market will witness growth in the forthcoming years. it has been observed that the American cryostem and celgene cellular therapeutics have their stem cell therapy candidates for the treatment of multiple sclerosis in phase I stage of development.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cell Therapy for Multiple Sclerosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cell Therapy for Multiple Sclerosis market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Therapy for Multiple Sclerosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Therapy for Multiple Sclerosis market.

Global Stem Cell Therapy for Multiple Sclerosis Scope and Market Size

Stem Cell Therapy for Multiple Sclerosis market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy for Multiple Sclerosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Intravenous

Intracerebroventricular

Relapsing-Remitting Multiple Sclerosis (RRMS)

Primary Progressive Multiple Sclerosis (PPMS)

Secondary Progressive Multiple Sclerosis (SPMS)

Progressive Relapsing Multiple Sclerosis (PRMS)

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

American CryoStem

Athersys

Celgene Cellular Therapeutics

Cell Cure Neurosciences

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Intravenous

1.2.3 Intracerebroventricular

1.3 Market by Application

1.3.1 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Relapsing-Remitting Multiple Sclerosis (RRMS)

1.3.3 Primary Progressive Multiple Sclerosis (PPMS)

1.3.4 Secondary Progressive Multiple Sclerosis (SPMS)

1.3.5 Progressive Relapsing Multiple Sclerosis (PRMS)

1.4 Study Objectives

1.5 Years Considered

2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Perspective (2017-2028)

2.2 Stem Cell Therapy for Multiple Sclerosis Growth Trends by Region

2.2.1 Stem Cell Therapy for Multiple Sclerosis Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Region (2017-2022)

2.2.3 Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Region (2023-2028)

2.3 Stem Cell Therapy for Multiple Sclerosis Market Dynamics

2.3.1 Stem Cell Therapy for Multiple Sclerosis Industry Trends

2.3.2 Stem Cell Therapy for Multiple Sclerosis Market Drivers

2.3.3 Stem Cell Therapy for Multiple Sclerosis Market Challenges

2.3.4 Stem Cell Therapy for Multiple Sclerosis Market Restraints

3.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue

3.1.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue (2017-2022)

3.1.2 Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Players (2017-2022)

3.2 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Stem Cell Therapy for Multiple Sclerosis Revenue

3.4 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio

3.4.1 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Multiple Sclerosis Revenue in 2021

3.5 Stem Cell Therapy for Multiple Sclerosis Key Players Head office and Area Served

3.6 Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service

3.7 Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Type (2017-2022)

4.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2023-2028)

5.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Application (2017-2022)

5.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2023-2028)

6.1 North America Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)

6.2 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)

6.3 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)

7.2 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)

7.3 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8.1 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)

8.2 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)

8.3 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9.1 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)

9.2 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)

9.3 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10.1 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)

10.2 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)

10.3 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11.1 American CryoStem

11.1.1 American CryoStem Company Detail

11.1.2 American CryoStem Business Overview

11.1.3 American CryoStem Stem Cell Therapy for Multiple Sclerosis Introduction

11.1.4 American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)

11.1.5 American CryoStem Recent Development

11.2 Athersys

11.2.1 Athersys Company Detail

11.2.2 Athersys Business Overview

11.2.3 Athersys Stem Cell Therapy for Multiple Sclerosis Introduction

11.2.4 Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)

11.2.5 Athersys Recent Development

11.3 Celgene Cellular Therapeutics

11.3.1 Celgene Cellular Therapeutics Company Detail

11.3.2 Celgene Cellular Therapeutics Business Overview

11.3.3 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Introduction

11.3.4 Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)

11.3.5 Celgene Cellular Therapeutics Recent Development

11.4 Cell Cure Neurosciences

11.4.1 Cell Cure Neurosciences Company Detail

11.4.2 Cell Cure Neurosciences Business Overview

11.4.3 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Introduction

11.4.4 Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)

11.4.5 Cell Cure Neurosciences Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Key Players of Intravenous

    Table 3. Key Players of Intracerebroventricular

    Table 4. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 5. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 6. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2017-2022) & (US$ Million)

    Table 7. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2017-2022)

    Table 8. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 9. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2023-2028)

    Table 10. Stem Cell Therapy for Multiple Sclerosis Market Trends

    Table 11. Stem Cell Therapy for Multiple Sclerosis Market Drivers

    Table 12. Stem Cell Therapy for Multiple Sclerosis Market Challenges

    Table 13. Stem Cell Therapy for Multiple Sclerosis Market Restraints

    Table 14. Global Stem Cell Therapy for Multiple Sclerosis Revenue by Players (2017-2022) & (US$ Million)

    Table 15. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players (2017-2022)

    Table 16. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2021)

    Table 17. Ranking of Global Top Stem Cell Therapy for Multiple Sclerosis Companies by Revenue (US$ Million) in 2021

    Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue (CR5 and HHI) & (2017-2022)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service

    Table 21. Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2017-2022) & (US$ Million)

    Table 24. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2017-2022)

    Table 25. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 26. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2023-2028)

    Table 27. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2017-2022) & (US$ Million)

    Table 28. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Application (2017-2022)

    Table 29. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 30. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Application (2023-2028)

    Table 31. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022) & (US$ Million)

    Table 32. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028) & (US$ Million)

    Table 33. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022) & (US$ Million)

    Table 34. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028) & (US$ Million)

    Table 35. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2017-2022) & (US$ Million)

    Table 36. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2023-2028) & (US$ Million)

    Table 37. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022) & (US$ Million)

    Table 38. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028) & (US$ Million)

    Table 39. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022) & (US$ Million)

    Table 40. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028) & (US$ Million)

    Table 41. American CryoStem Company Detail

    Table 42. American CryoStem Business Overview

    Table 43. American CryoStem Stem Cell Therapy for Multiple Sclerosis Product

    Table 44. American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022) & (US$ Million)

    Table 45. American CryoStem Recent Development

    Table 46. Athersys Company Detail

    Table 47. Athersys Business Overview

    Table 48. Athersys Stem Cell Therapy for Multiple Sclerosis Product

    Table 49. Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022) & (US$ Million)

    Table 50. Athersys Recent Development

    Table 51. Celgene Cellular Therapeutics Company Detail

    Table 52. Celgene Cellular Therapeutics Business Overview

    Table 53. Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Product

    Table 54. Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022) & (US$ Million)

    Table 55. Celgene Cellular Therapeutics Recent Development

    Table 56. Cell Cure Neurosciences Company Detail

    Table 57. Cell Cure Neurosciences Business Overview

    Table 58. Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Product

    Table 59. Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022) & (US$ Million)

    Table 60. Cell Cure Neurosciences Recent Development

    Table 61. Research Programs/Design for This Report

    Table 62. Key Data Information from Secondary Sources

    Table 63. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Type: 2021 VS 2028

    Figure 2. Intravenous Features

    Figure 3. Intracerebroventricular Features

    Figure 4. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application in 2021 & 2028

    Figure 5. Relapsing-Remitting Multiple Sclerosis (RRMS) Case Studies

    Figure 6. Primary Progressive Multiple Sclerosis (PPMS) Case Studies

    Figure 7. Secondary Progressive Multiple Sclerosis (SPMS) Case Studies

    Figure 8. Progressive Relapsing Multiple Sclerosis (PRMS) Case Studies

    Figure 9. Stem Cell Therapy for Multiple Sclerosis Report Years Considered

    Figure 10. Global Stem Cell Therapy for Multiple Sclerosis Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 11. Global Stem Cell Therapy for Multiple Sclerosis Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 12. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Region: 2021 VS 2028

    Figure 13. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players in 2021

    Figure 14. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2021)

    Figure 15. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue in 2021

    Figure 16. North America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 17. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2017-2028)

    Figure 18. United States Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 19. Canada Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 20. Europe Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2017-2028)

    Figure 22. Germany Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 23. France Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 24. U.K. Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 25. Italy Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 26. Russia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. Nordic Countries Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2017-2028)

    Figure 30. China Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Japan Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. South Korea Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 33. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 34. India Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 35. Australia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 36. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. Latin America Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2017-2028)

    Figure 38. Mexico Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. Brazil Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2017-2028)

    Figure 42. Turkey Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 43. Saudi Arabia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 44. American CryoStem Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)

    Figure 45. Athersys Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)

    Figure 46. Celgene Cellular Therapeutics Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)

    Figure 47. Cell Cure Neurosciences Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)

    Figure 48. Bottom-up and Top-down Approaches for This Report

    Figure 49. Data Triangulation

    Figure 50. Key Executives Interviewed